Previous 10 | Next 10 |
Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors PR Newswire SECAUCUS, N.J. , May 16, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it...
2024-05-16 00:49:57 ET More on Quest Diagnostics Quest Diagnostics: Let's Keep Waiting Quest Diagnostics said to be nearing deal for Canada's Lifelabs Quest Diagnostics to acquire assets of PathAI Diagnostics Seeking Alpha’s Quant Rating on Quest Diagn...
2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...
Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests PR Newswire Overall Drug Positivity Holds Steady at Historically High Rates while Marijuana Positivity Continued Upward Climb in the General U.S...
2024-05-13 22:19:41 ET Summary Davis Selected Advisers' 13F portfolio value increased to $17.84B, with a decrease in the number of holdings from 103 to 98. The top three holdings in the portfolio are Berkshire Hathaway, Meta Platforms, and Capital One Financial. Stake increase...
2024-05-13 14:45:30 ET More on Quest Diagnostics Quest Diagnostics: Let's Keep Waiting Quest Diagnostics Incorporated (DGX) Q1 2024 Earnings Call Transcript Quest Diagnostics to acquire assets of PathAI Diagnostics Quest Diagnostics, LabCorp climb following F...
NORTHAMPTON, MA / ACCESSWIRE / May 13, 2024 / Quest Diagnostics Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists. As part of the celebration, we also featured highlights of the prof...
NORTHAMPTON, MA / ACCESSWIRE / May 8, 2024 / Quest Diagnostics The idea of getting a blood draw can produce a variety of feelings for many patients at Quest. For one patient in New Jersey, the experience of visiting a Patient Service Center (PSC) has turned into one they felt the need to share...
2024-05-07 23:02:33 ET Summary Quest Diagnostics is a leading provider of diagnostic testing services with a strong market position and consistent financial performance. The company's valuation metrics, including a P/E ratio of 15.2x, P/B ratio of 3.2x, and EV/EBITDA ratio of 11.8...
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference PR Newswire SECAUCUS, N.J. , May 7, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Da...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 PR Newswire Second quarter revenues of $2.40 billion , up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03 , down 1.0% from 2023; a...